Lung MORphological Modifications Evaluated by Electrical Impedance Tomography During Preoxygenation for the Intubation of Hypoxemic Patients: Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation (MORPHEIT Study, an Ancillary Study of PREONIV Trial)
MORPHEIT
2 other identifiers
interventional
30
1 country
1
Brief Summary
Prospective, randomized clinical multicentric study, in ICU, during preoxygenation for the intubation of hypoxemic patients. Electrical impedance tomographic evaluation of lung morphology variations according to the preoxygenation technique : Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedFirst Submitted
Initial submission to the registry
September 4, 2017
CompletedFirst Posted
Study publicly available on registry
September 13, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedSeptember 14, 2017
September 1, 2017
1.2 years
September 4, 2017
September 13, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
evolution of lung aeration evaluated by electrical impedance tomography during the preoxygenation for intubation of hypoxemic patients and the arterial blood oxygenation
at day 1
Secondary Outcomes (9)
electrical impedance tomography related indexes
at day 1 (before, during and after preoxygenation and at 5 minutes and at 30 minutes after intubation)
Lung inhomogeneity index
at day 1 (during and after preoxygenation and at 5 minutes and at 30 minutes after intubation)
End expiratory lung impedance
at day 1 (during and after preoxygenation and at 5 minutes and at 30 minutes after intubation)
Center of Ventilation
at day 1 (during and after preoxygenation and at 5 minutes and at 30 minutes after intubation)
Tidal Volume
at day 1 (during and after preoxygenation and at 5 minutes and at 30 minutes after intubation)
- +4 more secondary outcomes
Study Arms (3)
standard oxygenation
EXPERIMENTALElectrical impedance tomographic evaluation of lung morphology variations according to the preoxygenation technique : Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation
High flow nasal oxygen therapy
OTHERElectrical impedance tomographic evaluation of lung morphology variations according to the preoxygenation technique : Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation
NonInvasive Ventilation
OTHERElectrical impedance tomographic evaluation of lung morphology variations according to the preoxygenation technique : Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation
Interventions
Electrical impedance tomographic evaluation of lung morphology variations according to the preoxygenation technique : Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation
Electrical impedance tomographic evaluation of lung morphology variations according to the preoxygenation technique : Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation
Electrical impedance tomographic evaluation of lung morphology variations according to the preoxygenation technique : Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation
Eligibility Criteria
You may qualify if:
- adults patients
- requiring intubation and hypoxemia (defined by PaO2/FiO2 below 200)
- patient covered by french health care system
- patient included in Hopital Estaing, Clermont-Ferrand
You may not qualify if:
- patient refusal
- intubation for other causes (excluding hypoxemia)
- impossibility to measure pulse oxymetry value
- contraindication for NIV : vomiting
- NIV intolerance
- cardiac arrest during intubation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas GODET
University Hospital, Clermont-Ferrand
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking Details
- open
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2017
First Posted
September 13, 2017
Study Start
June 2, 2016
Primary Completion
September 1, 2017
Study Completion
October 1, 2017
Last Updated
September 14, 2017
Record last verified: 2017-09